(POAI) – Company Press Releases
-
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
-
Predictive Oncology to Participate in Upcoming Investor Conferences
-
Predictive Oncology to Participate in Upcoming San Francisco Conferences
-
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
-
Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
-
Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023
-
Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
-
Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board
-
Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board
-
Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention
-
Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update
-
Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023
-
Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors
-
Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors
-
Predictive Oncology Announces Reverse Stock Split
-
Predictive Oncology Announces Reverse Stock Split
-
Predictive Oncology Adjourns Special Meeting of Stockholders
-
Predictive Oncology Adjourns Special Meeting of Stockholders
-
Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board
-
Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board
-
Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy
-
Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy
-
Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update
-
Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update
-
Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs
-
Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs
-
Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
-
Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
-
Predictive Oncology Engages LifeSci Advisors as Strategic Investor Relations Partner
-
Predictive Oncology Engages LifeSci Advisors as Strategic Investor Relations Partner
-
Predictive Oncology Issues Letter to Shareholders
-
Predictive Oncology Issues Letter to Shareholders
-
Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligence
-
Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligence
-
Predictive Oncology launches ACE program to partner with academic and research institutions to advance their drug discovery initiatives
-
Predictive Oncology launches ACE program to partner with academic and research institutions to advance their drug discovery initiatives
-
Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business Officer
-
Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business Officer
-
Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive Oncology
-
Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive Oncology
-
Distinguished Innovator in Genomics Joins the Scientific Advisory Board of Predictive Oncology
-
Distinguished Innovator in Genomics Joins the Scientific Advisory Board of Predictive Oncology
-
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors
-
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors
-
Predictive Oncology Reports Third Quarter Financial Results
-
Predictive Oncology Reports Third Quarter Financial Results
-
David S. Smith appointed to the Board of Directors of Predictive Oncology
Back to POAI Stock Lookup
